Blood markers for HPV-positive throat cancer
Part of Cancer clinical trials.
This study looks at blood samples to find markers that may predict how well treatment works for HPV-positive throat cancer. It aims to help doctors tailor treatment in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have throat or tonsil cancer that is HPV-positive (confirmed by a biopsy test).
- The cancer must not have spread to distant parts of the body (like lungs or liver).
- You need to be able to have standard treatment with chemotherapy and radiation.
- You must be willing to have multiple blood draws during treatment.
- You cannot have a pacemaker or similar implanted electronic device (because of MRI scans).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if monitoring cancer DNA left in your blood after surgery can help decide if you need additional treatment. It is for people with HPV-positive oropharynx (throat) cancer who have a certain amount of cancer DNA detected before surgery.
This study checks a blood test that looks for HPV tumor DNA to help doctors decide when to start routine treatment after surgery. It may help some people avoid starting treatment too early or too late based on how the test changes after the operation.
This study tests whether patients with a specific type of HPV-positive throat cancer can safely skip radiation after surgery by using blood tests to monitor for cancer recurrence. The goal is to reduce side effects while keeping patients cancer-free.
This Phase 2 study tests a “risk-adapted” treatment plan for HPV-related throat cancer, using an HPV DNA blood test to help decide how treatment is done. If your baseline blood test shows detectable HPV DNA, the study may help tailor therapy to your risk and potentially improve outcomes while limiting unnecessary treatment.
This trial tests whether giving lower doses of radiation to certain parts of the throat can be just as effective as standard doses, while reducing side effects. It is for people with HPV-positive throat cancer, which tends to respond well to treatment.
This study looks for certain markers in people with HPV-related throat cancer that could help doctors choose the best treatment. If you are planning to have surgery for your throat cancer, you may be able to join.
Hear when a new HPV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.